For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
A synthetic peptide corresponding to residues on the C terminus of human CD21
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
This product is available conjugated to DyLight® 488 see ab139873.
Our Abpromise guarantee covers the use of ab75985 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"